Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer

Related Experiment Video

Updated: Aug 8, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Hans-Georg Rammensee1

  • 1Interfakultäres Institut für Zellbiologie, Abteilung Immunologie, Eberhard Karls Universität, Tübingen, Germany. rammensee@uni-tuebingen.de

Immunology and Cell Biology
|May 10, 2006
PubMed

Insights

Active cancer immunization strategies face challenges. This study explores peptides and messenger RNA (mRNA) as potential T-cell antigens for cancer vaccines, considering practical implementation.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Active immunization against established cancer is an emerging therapeutic area.
  • Current approaches face significant challenges and limitations.

Purpose of the Study:

  • To discuss the potential of peptides as minimal essential T-cell antigens.
  • To evaluate messenger RNA (mRNA) as a novel antigen delivery platform for cancer vaccines.
  • To consider the practical aspects of implementing these strategies.

Main Methods:

  • Review and discussion of existing literature on cancer vaccines.
  • Analysis of peptide-based antigens for T-cell activation.
  • Evaluation of mRNA technology for antigen presentation in cancer immunotherapy.

Main Results:

  • Peptides offer a defined set of T-cell epitopes for targeted immune responses.
  • mRNA presents advantages as a vaccine platform, including flexibility and rapid development.
  • Practical considerations for manufacturing, delivery, and stability are crucial.

Conclusions:

  • Both peptides and mRNA hold promise for active cancer immunization.
  • Further research and development are needed to overcome practical hurdles.
  • Optimizing antigen selection and delivery systems is key for effective cancer vaccines.

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.